An Arizona court decision that essentially prohibits American farmers from using dicamba for over-the-top spraying on soybeans and cotton will not stop Canadian growers from using the herbicide this year, says Bayer Crop Science Canada.
U.S. dicamba ruling won’t touch Canada: Bayer
Thousands of American farmers who have already bought the herbicide now in a bind after court bans over-the-top use
US court cancels approvals for widely used dicamba weedkillers
EPA violated procedures mandating public input, judge rules
A U.S. court has nullified the government's latest approvals of certain agricultural weedkillers sold by Bayer, BASF and Syngenta, fueling uncertainty among farmers who spray the products on soybeans and cotton genetically engineered to resist them.
Crop-killing weeds advance across US farmland as chemicals lose effectiveness
Losing battle with weeds adds pressures to farmers already stressed by inflation, extreme weather
Crop-killing weeds such as kochia are advancing across the U.S. northern plains and Midwest, in the latest sign that weeds are developing resistance to chemicals faster than companies including Bayer BAYGn.DE and Corteva CTVA.N can develop new ones to fight them.
Bayer’s crop marketing, crop production platforms in sync
FieldView, Combyne platforms now integrated
Combyne, the made-in-Canada grain marketing platform Bayer bought earlier this year, is now fully on speaking terms with the company’s Climate FieldView precision ag platform. Bayer on Oct. 30 announced integration of the two platforms, which it said will allow grain farmers in Canada and the U.S. to connect their marketing data in Combyne and […] Read more
Appeals court blocks California warning labels for glyphosate
Decision important in ongoing lawsuits, Bayer says
Reuters — A divided U.S. federal appeals court on Tuesday said California cannot require businesses to warn consumers about the potential dangers of glyphosate, an ingredient in Roundup herbicide that has been linked to cancer. Upholding a permanent injunction, the Ninth U.S. Circuit Court of Appeals in San Francisco found it unconstitutional to force Bayer’s […] Read more
Bayer slashes outlook as glyphosate demand weakens further
Analysts say dry weather conditions hurt farmers' demand for seeds and pesticides
Reuters – Further deterioration in demand for glyphosate-based weed killers led Bayer BAYGn.DE to cut its full-year earnings outlook and announce a 2.5 billion euro ($2.8 billion USD) write-down on glyphosate-related assets. In an unscheduled statement late on Monday, the German drugs and pesticides maker said it was projecting 2023 earnings before interest, taxes, depreciation […] Read more
Bayer settles with New York over Roundup safety claims
Company blocked from advertising product as non-toxic
New York | Reuters — Bayer agreed on Thursday to pay US$6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup, which has been linked to cancer, as environmentally safe. The settlement resolves accusations that Bayer and its Monsanto unit failed to substantiate their repeated claims […] Read more
Bayer under investor pressure to speed up CEO changeover
Drug and chem firm's stock in 'crisis of trust,' investor says
Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, Bayer shares have been weighed […] Read more
Activist investor reported building stake in Bayer, seeking breakup
Bayer up for 'constructive dialogue'
Reuters — Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources. U.K.-based Bluebell is also seeking an overhaul of Bayer’s corporate governance, the report added. A Bayer spokesperson, who declined to comment on […] Read more
Bayer’s agriculture unit, consumer health drive outlook hike
Frankfurt | Reuters – Agriculture and pharmaceuticals company Bayer BAYGn.DE on Thursday lifted its 2022 earnings guidance on strong demand from farmers for its seeds and crop chemicals and higher sales of consumer health products. Bayer is now targeting earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, of about 13 billion […] Read more